Cabinet approves bill on biotechnology centre in Faridabad
New Delhi: The union cabinet, at a meeting chaired by Prime Minister Narendra Modi, gave its approval for introduction of a bill concerning Regional Biotechnology centre in Faridabad to grant autonomous status to it.“The objective of the bill is to provide a legal status to the centre so as to function independently as an autonomous body and also an institution of national importance...
Login or Register to read the full article
New Delhi: The union cabinet, at a meeting chaired by Prime Minister Narendra Modi, gave its approval for introduction of a bill concerning Regional Biotechnology centre in Faridabad to grant autonomous status to it.
“The objective of the bill is to provide a legal status to the centre so as to function independently as an autonomous body and also an institution of national importance for education, training and research in the areas of biotechnology,” an official release said.
It said the centre has already been established by an executive order of the government in November 2008 and is operational at present at the NCR Biotech Science Cluster, Faridabad.
The centre is a regional hub for interdisciplinary education, training and research in biotechnology with emphasis on novel education programmes relevant to industry including bio-drug discovery science, nano-science and medicine, imaging techniques, designer crops, bioengineering and bio-materials and intellectual property.
“The objective of the bill is to provide a legal status to the centre so as to function independently as an autonomous body and also an institution of national importance for education, training and research in the areas of biotechnology,” an official release said.
It said the centre has already been established by an executive order of the government in November 2008 and is operational at present at the NCR Biotech Science Cluster, Faridabad.
The centre is a regional hub for interdisciplinary education, training and research in biotechnology with emphasis on novel education programmes relevant to industry including bio-drug discovery science, nano-science and medicine, imaging techniques, designer crops, bioengineering and bio-materials and intellectual property.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd